BioNTech, Pfizer vaccine neutralises Omicron with three shots
Published by Reuters (Reuters) – BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed. In the first official statement from vaccine manufacturers